• New, larger venue of Convene 133 Houndsditch, central London, offers increased capacity, additional partnering space, improved networking opportunities, and a dual track of R&D showcase opportunities
  • Programme features keynote from Tim Haines, Executive Partner at Abingworth, with a review of the life sciences investment landscape
  • Register online for in-person event, taking place 23-24 April, in London

Oxford and London, UK, 10 April 2024: OBN (UK) Ltd., the membership organisation whose mission is to catalyse growth in the life sciences industry, is pleased to invite R&D companies, professionals and investors from across the life sciences and pharma industries to attend BioTrinity 2024 in London from 23-24 April.

Building on the success of last year’s event, BioTrinity 2024 features three dedicated presentation tracks: two science focused tracks including spotlights on oncology, rare diseases, and digital health, and one business focused track, offering industry leaders the opportunity to share their experiences in entrepreneurship and investment.

The 2-day conference is expected to see a record number of delegates, comprising early-stage and emerging life science R&D companies, investors, big pharma, academics, charities, government, and a broad range of valued service providers. With dedicated spaces for private meetings powered by PartneringOne, and an all-delegate Networking Party, the event offers extensive opportunities for face-to-face discussions.

New this year, BioTrinity 2024 includes academic poster presentations from life science academics and early-career professionals. Incorporated into the event programme, the poster sessions will showcase some of the most entrepreneurial, translatable, or commercially viable ideas from academia.

Stuart Rose, CEO of OBN, said: “BioTrinity 2024 is set to be bigger than ever; our new venue at Convene 133 Houndsditch offers a great space for an increased number of delegates and plenty of opportunities for networking, while our three tracks of showcases and panels provide a fantastic platform for sharing industry knowledge and experience. We look forward to welcoming our supporters and sponsors in April for an exciting two days of collaboration and discussions as we continue to catalyse growth across the UK Life Sciences industry.”

To access the full event programme of speakers and sessions and to register, please visit: https://obn.glueup.com/event/biotrinity-2024-80960/home.html l.

Follow OBN on X (formerly Twitter) (@OBN_UK) and LinkedIn (OBN UK) for updates on this event, and more.